A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

Participation in the 340B Drug Pricing Program does not increase the use of targeted therapy in older patients with advanced prostate cancer, a study suggests.

(AUAER) is proud to announce a collaboration with Pfizer Medical Grants & Partnerships (GMGP) to offer $1.5 million in grant funding to urology and urologic oncology health institutions and ...

Researchers say they have been encouraged by trials of a new process to detect prostate cancer in men. It is hoped that the ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

This joint Request for Proposals (RFP) is designed to address critical gaps in patient care for individuals with advanced prostate cancer (APC) and support novel quality improvement, solution ...

An ultrasound test that takes less than 20 minutes could improve the accuracy of prostate cancer diagnosis, scientists say.

Nearly half of high-risk prostate cancer patients classified as nonmetastatic by traditional imaging show metastases when ...